Scleroderma Antibody (Scl-70)

The Scleroderma Antibody (Scl-70) test contains 1 test with 1 biomarker.

Scleroderma Antibody (Scl-70)

Clinical Significance

Scl-70 antibody is present in approximately 40% of patients with progressive systemic sclerosis (PSS).

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Scl70 Antibody

Scl-70 Antibody

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.

Customer Reviews